Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Centre Experience
Open Access
- 4 September 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (6) , 3373-3384
Abstract
Aims: Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trials have shown that BAT improves walking distance and reduces N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels at least in patients with only moderate elevation at baseline. Its impact on the risk of heart failure hospitalization (HFH) and death is not yet established, and experience in clinical routine is limited. Methods and results: We report on patient characteristics and clinical outcome in a retrospective, non-randomized single-centre registry of BAT in HFrEF. Patients in the New York Heart Association (NYHA) Classes III and IV with a left ventricular ejection fraction (LVEF) 1600 pg/mL, or estimated glomerular filtration rate (eGFR) <30 mL/min at baseline. NYHA class and eGFR were independent predictors of mortality. Conclusions: Patients with HFrEF who are selected for BAT are in a stage of worsening or even advanced heart failure. BAT appears to be safe and improves clinical symptoms and—to a modest degree—left ventricular function. The risk of death remains high in advanced disease stages. Patient selection seems to be crucial, and the impact of BAT in earlier disease stages needs to be established.Keywords
This publication has 28 references indexed in Scilit:
- The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fractionEuropean Heart Journal, 2015
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studiesEuropean Heart Journal, 2012
- Effects of Chronic Baroreceptor Stimulation on the Autonomic Cardiovascular Regulation in Patients With Drug-Resistant Arterial HypertensionHypertension, 2009
- Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart FailureCirculation, 2007
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart FailureCirculation, 1995
- Left ventricular filling and stress response pattern in essential hypertensionThe American Journal of Medicine, 1991
- IS THERE AUTONOMIC IMPAIRMENT IN CONGESTIVE (DILATED) CARDIOMYOPATHY?The Lancet, 1981
- Defective Cardiac Parasympathetic Control in Patients with Heart DiseaseNew England Journal of Medicine, 1971